// App-Quantinova.ai

WP043 : Circulating tumor cells (CTCs) and Autologous hematopoietic stem cell transplantation in triple negative metastatic breast cancer

Researchers

Presenter

  • J. M. Reuben

Principal Investigators

  • M. Mego

  • H. Gao

  • N. T. Ueno

Medical Centers

  • Hematopathology-Res, MD Anderson Cancer Center, Houston, United States,

  • Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX

  • National Cancer Institute, Bratislava, Slovakia

Locations

  • United States

  • Slovakia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • C-X-C motif chemokine receptor 4

  • Epidermal growth factor receptor

  • Epithelial Cell Adhesion Molecule

  • erb-b2 receptor tyrosine kinase 2

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved